owning cryptocurrency Featured snippets

Deutsche Bank appointed MARCUS CHROMIK as the new CRO.After the European Central Bank announced the interest rate decision, EUR/USD rose 15 points to 1.0484.Trade union representative: STELLANTIS told us that the output of Italy in 2025 will be similar to this year, about 500,000 vehicles.

Indian Minister of Steel: Considering the growth of domestic consumption, there is no possibility of assets stranded in the future.Deutsche Bank appointed MARCUS CHROMIK as the new CRO.Russia's central bank's gold and foreign exchange reserves reached US$ 614.4 billion in the week of December 6, with the previous value of US$ 614.1 billion.

Guoxuan Hi-Tech: China, the strategic shareholder, continued to give up voting rights. Guoxuan Hi-Tech announced that Guoxuan Holdings, Li Zhen and Jerry Lee (collectively referred to as the "founding shareholders") and China, the strategic shareholder of the company, signed a Supplementary Agreement on the Shareholders' Agreement of Guoxuan Hi-Tech Co., Ltd., and Volkswagen China agreed to extend the commitment period of giving up voting rights. That is to say, within 72 months after the relevant shares of the company involved in the non-public offering and share transfer are registered in the name of Volkswagen China or within a longer period determined by Volkswagen China, it will irrevocably give up the voting rights of some of its shares in the company, so that the voting rights of Volkswagen China will be at least 5% lower than that of the founding shareholder. Volkswagen China's extension of the period of giving up its voting rights commitment this time will not lead to the change of the company's control rights and will not affect the normal production and operation of the company. Mr. Li Zhen remains the actual controller of the company.Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).German two-year bonds recovered their decline and the yield was flat at 1.95%.